Eric R. Fearon, MD, PhD

U-M Genetic Medicine Division, Dr. Eric Fearon
Eric R. Fearon, MD, PhD

Emanuel N. Maisel Professor of Oncology
Director, University of Michigan Rogel Cancer Center
Professor, Departments of Internal Medicine, Pathology, and Human Genetics

Biomedical Science Research Building
109 Zina Pitcher Place, Room 1506
Ann Arbor, MI 48109
Phone: 734-936-1831
 
 
 

Credentials

  • BA (Biophysics), Johns Hopkins University, Baltimore, MD, 1983
  • MD, Johns Hopkins University School of Medicine, Baltimore, MD, 1990
  • PhD (Biology/Program in Human Genetics; Mentor: Dr. Bert Vogelstein), Johns Hopkins University, Baltimore, MD, 1990
  • Postdoctoral Training, Johns Hopkins University School of Medicine, Baltimore, MD, Hematology Division, Department of Medicine & Oncology Center (Mentor: Dr. Chi Van Dang), 1992

Research Interests

Molecular analysis of cancer pathogenesis; βeta-catenin-dependent Wnt signaling; transgenic and knockout mouse models of colon cancer; miRNAs and cancer; CDX2 homeobox gene function.

The research in the Fearon laboratory seeks to address the means by which specific oncogene and tumor suppressor gene defects contribute to the pathogenesis of colon and other cancers and to develop novel strategies for early detection and treatment of colorectal adenomas and carcinomas.

Biography

View Dr. Fearon's biography.

Publications

View all Dr. Fearon's publications in PubMed.

Honors & Awards

  • 1983: Phi Beta Kappa, Johns Hopkins University
  • 1983: Martin G. Larrabee undergraduate prize for research in biophysics, Johns Hopkins University
  • 1990: Alpha Omega Alpha Honor Medical Society, Johns Hopkins University School of Medicine
  • 1990: David Israel Macht Prize for Basic Science Research, Johns Hopkins University School of Medicine
  • 1990: Wilson S. Stone Award, UT, M.D. Anderson Cancer Center
  • 1992-1995: McDonnell Fellow in Molecular Medicine in Cancer Research, James S. McDonnell Fund
  • 1994: Ruppert B. Turnbull Memorial Lectureship, Visiting Professor, Department of Surgery, Jewish Hospital of St. Louis and Washington University School of Medicine
  • 1996: Louis J. Cole Lecture, Faculty of Medicine, University of Toronto
  • 1997: Co-Organizer, Keystone Syposium on “Genetics of Human Cancer: Pathogenesis and Diagnosis”
  • 1998: American Society for Clinical Investigation
  • 2000: Lynch Lectureship, University of Notre Dame, Department of Biology, Molecular Biosciences Program
  • 2001: Vice Chair, Gordon Research Conference on Cancer (Newport, RI)
  • 2002: Chair, Gordon Research Conference on Cancer (Newport, RI)
  • 2001: Association of American Physicians
  • 2005: Third Annual DSR Sarma Lectureship in Oncologic Pathology, University of Toronto
  • 2007: Johns Hopkins University Society of Fellows
  • 2009: Co-organizer, Keystone Symposium on “Emerging Themes in Tumor Suppressors: Function and Clinical Implications in the Post-Genomic Era”
  • 2012: Shapiro Lecture, University of Pennsylvania, Division of Gastroenterology
  • 2013: Institute of Medicine of the National Academies